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Abstract
The hippocampus is a structure in the brain crucial for learning and memory. This occurs by
synaptic remodeling known as long term potentiation and long term depression. Modifications of
proteins in the hippocampus can affect its function. One of these modifications is the addition of
O-linked β-N-acetylglucosamine, also known as O-GlcNAc. This is a sugar produced from
glucose by the hexosamine biosynthetic pathway that is reversibly added onto serine and
threonine residues of proteins by O-GlcNAc Transferase, or OGT. It is reversibly removed from
these residues by O-GlcNAcAse, or OGA. This modification has been implicated in diabetes,
cardiac dysfunction, and neurodegenerative diseases. Furthermore, as the gene coding for OGT
is located on the X chromosome, the two copies of this chromosome in females may lead to
differential expression of OGT. Connectivity, structure, and hormone differences in male and
female brains may likewise impact expression in the brain between sexes. A transgenic, or
mutated, mouse model can be generated that prevents OGA expression when the mouse is taking
a medication known as doxycycline. This is hypothesized to increase O-GlcNAc levels. Due to
the prevalence of O-GlcNAc in various diseases of the brain, this study aimed to validate how
levels of OGA, O-GlcNAc, and OGT are related in the hippocampus of mice both on and off
doxycycline, and if expression differed between sexes. This was accomplished by western blot
analysis. No significant differences were found between wild type and mutant mice, whether
male or female and whether on or off doxycycline. These results indicate that the amount of time
off doxycycline needed to impact OGA levels was not reached, and that male and female
hippocampi express similar amounts of OGA and OGT. Future experiments may investigate how
OGA, OGT, and O-GlcNAcylated protein levels differ by sex in other regions of the brain and
subregions of the hippocampus. Other future studies may examine if longer time off doxycycline
would change OGA and O-GlcNAc levels in the mouse hippocampus.

KEY WORDS: O-GlcNAcylation, Hippocampus, Western Blot, Tet-off System
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Introduction
The brain is a highly plastic structure that goes through frequent shifts. Learning and
memory take place in this structure, specifically in the hippocampus. This is a region with many
excitatory pathways that is crucial in the processes of long-term potentiation and depression.1
This region exhibits sexual dimorphisms resulting from differential responses to glucocorticoids
and sex hormone modulation.2, 3 It is one of the areas of the brain most highly modified with
O-linked β-N-acetylglucosamine, or O-GlcNAc. 4 This modification is akin to phosphorylation
and indicates the metabolic state of the body.5, 6 It is implicated in many diseases, especially
those related to glucose metabolism. The enzymes O-GlcNAc Transferase, or OGT and
O-GlcNAcAse, or OGA, regulate the addition and removal of this sugar. 7 This modification may
also differ between males and females as the gene encoding for OGT is located on the X
chromosome. 6 Therefore, this study will present a background on the hippocampus, learning,
and memory in this structure, sexual dimorphisms in brain, O-GlcNAcylation, and implications
for disease pathology. This will precede an investigation into specific differences in
hippocampal O-GlcNAc, OGT, and OGA levels. Mice with pharmacologically regulated levels
of these products and wild type mice of both sexes were analyzed. Western blot analysis was
used to perform this investigation.
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Review of Literature
Brain and hippocampus
The hippocampus is a structure of the brain that, along with the dentate gyrus and
subiculum, is a part of the hippocampal formation. This structure is located above the lateral
ventricle and next to the temporal lobe. However, it comes to reside in this position by migration
from an embryological placement dorsal to the thalamus. It is crescent-shaped and divided into
four zones deemed CA1, CA2, CA3, and CA4.1 Division along the lateral axis distinguishes the
dorsal, medial, and ventral functional parts.8 Along the longitudinal axis, place cells can be found
that increase in size moving from the dorsal to ventral areas. The transverse axis is the location
of the trisynaptic loop. Further, hippocampal activity moves in the direction of dorsal to ventral.9
Figure 1. The hippocampus and its synaptic connections10
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The hippocampus has three layers. The first is the pyramidal cell layer, made of the
somas, or bodies, of pyramidal cells. These cells are efferent projecting neurons. The second
layer is composed of axons and the pyramidal cell dendrites and is called the molecular layer.
Interneurons make up the final layer, which is called the polymorphic layer.11 The hippocampus
is the only recipient of dentate gyrus projecting neurons. The septal nuclei and contralateral
hippocampal formation likewise project to the hippocampus. The inputs from the septal nuclei to
the hippocampus release the neurotransmitter acetylcholine at synapses. These form excitatory
pathways, as do the numerous glutamatergic inputs to the hippocampus.1 The efferent neurons in
the hippocampus are particularly susceptible to the effects of aging that decrease synaptic
plasticity and dendritic spine density.11
In contrast to these afferent projections, efferent projections from the hippocampus
typically utilize the neurotransmitters gamma-aminobutyric acid, or GABA, an inhibitory
neurotransmitter.1, 12 Efferents from the hippocampus largely extend from the CA1, with dorsal
area projecting to the subiculum and entorhinal cortex while the ventral area goes to the nucleus
accumbens, amygdala, and prefrontal cortex, or PFC.8 Projections to the PFC terminate in the
medial area and are unidirectional. These afferents interact with projections from the limbic
thalamus to the medial PFC.12, 13
A crucial role of the hippocampus is in learning and memory. Studies of hippocampal
damage initially led to this conclusion and were later verified through studies. Spatial memory
disorders and anterograde amnesia have been correlated to damage of the CA1 region.1
Excitatory inputs from the basolateral nucleus of the amygdala are crucial in spatial memory
formation. Place cells in the dorsal hippocampus encode associations to a particular location.
Additionally, the dorsal area is linked to episodic memory. Social memory, however, is correlated
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with the ventral area’s projections to the nucleus accumbens.8 New memories are processed by
the hippocampus before long term storage in the cortex. Processing in this structure is also
crucial to the formation of declarative, explicit, and recent memories.10
The hippocampus’s role in episodic and spatial memory means that it is critical in
determining context. The default in the hippocampus is to assume contextual sameness until a
threshold of significant change is established. This is a result of the maintenance of patterns with
slight changes of input. This is accomplished by dampening signals as they move from one place
field to the next within the hippocampus. Small movements through the world can therefore
establish smooth hippocampal activity and recognition of sameness. Nevertheless, inputs over a
particular threshold allow for a different pattern to be transmitted. Because the ventral medial
PFC is particularly concerned with context, it displays key communication with the ventral
hippocampus.9
Long term potentiation and memory in the hippocampus
In the brain, activity can modulate the strength of synaptic transmissions, or signals
between neurons. This concept is known as synaptic plasticity. Long-term plasticity is a result of
activity causing change in transmission that lasts for days, weeks, or years. Shifts in brain
plasticity are thought to be linked to memory formation and retention. The most well studied
forms of long-term plasticity are long-term potentiation and long-term depression, or LTP and
LTD.10
LTP and LTD in the hippocampus in particular are thought to underlie memory
formation. Quick, repeated excitatory inputs to a neuron that are linked to synaptic changes cause
this potentiation or depression. Typically, these excitatory inputs are glutamate neurotransmitters
that bind N-methyl-D-aspartate, or NMDA, receptors in the target neuron.1 These types of
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receptors are ionotropic glutamate receptors that are particularly prevalent in the hippocampus.1,2
Furthermore, the high concentration of NMDA receptors allows for the processing of two inputs
simultaneously, which is thought to be linked to associative memory formation. Binding of
glutamate allows calcium to flow into the target, leading to significant depolarization.1 Flow of
calcium ions in response to the binding of NMDA receptors has been specifically recorded in
inputs to the PFC from the hippocampus, causing excitatory postsynaptic potentials.13
The potential change resulting from NMDA calcium flow regulates the addition in LTP
or removal in LTD of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, or AMPA,
receptors into the synapse.5 AMPA receptors are another ionotropic glutamate receptor that
mediates fast excitatory transmission.2 They are frequently undergoing exocytosis or endocytosis
and diffusion within the cell membrane. The amount, composition, and properties of these
receptors modulate synaptic strength. Four types of subunits in this receptor exist, termed
GluA1-4. Further, the receptors can be post translationally modified in several different ways
that impact protein interactions. The ligand binding and transmembrane domains are largely the
same between receptors, but their cytoplasmic carboxy-termini and intracellular amino-termini
differ. Two forms of subunits exist, the first of which is long tailed, including GluA1, GluA4, and
a variant GluA2L, which are added to synapses based on activity and often added in the
development of LTP. The other subunit type is short tailed. This type, including GluA2, GluA3,
and variant GluA4S, undergoes constant cycling in and out of synapses. The relative
composition of subunits differs by cell. They assemble into tetramers to form the main ion
channel through the receptor.14 The receptors and ligands involved in this process can be seen in
Figure 2.
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Figure 2. Receptors and ligands in synaptic transmission10

AMPA channel permeability to calcium depends on the concentration of the subunit
GluA2, which prevents the flow of the ion.2 Because calcium ions are charged, their
concentration differences create a charge imbalance across the cell known as an electric
potential, or voltage. Thus, blockage of calcium ion flow can affect the voltage. Those without
GluA2, however, allow calcium to pass. These types are often found early in development and
have very high conductance, which leads to higher synaptic transmission.14
The amount and composition of AMPA receptors can result in long-term changes in
synaptic strengthening, shown by endplate synaptic potential recordings.5 These changes are
bidirectional, with increases resulting in LTP and a decrease in strength resulting in long-term
depression. Often, the particular mode of conditioning that is applied will change which of these
occurs. An example of this variation with conditioning includes frequency of stimulation, with
high frequencies inducing potentiation and low frequencies inducing depression. cAMP levels
also affect how the synapse changes, with higher concentrations resulting in potentiation.12 The
composition and modifications of particular AMPAs added to or removed from synapses impact
the particular change in synaptic strength. Certain forms of AMPA receptors are correlated with
particular forms of potentiation.5 An example of this includes calcium permeable AMPAs, whose
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high levels of transmission make them particularly suitable to prime synapses for LTP.14 As
differential amounts of AMPA receptors are associated with synapse strength, their density is
directly related to the formation of memory by LTP. This is because strengthened synapses are
associated with the formation of memory engrams.5 These strengthened synapses are also
reactivated with the recall of these memories.12
Due to the role of NMDA receptors in generating an increase in synaptic strength,
blocking these receptors can inhibit potentiation.12 Additionally, a decrease in protein kinase A is
related to decreased LTP.15 On the other hand, an increase in stimulation of cyclic adenosine
monophosphate, or cAMP, concentration inside the neuron can increase LTP.12 Shifts in
potentiation of the hippocampus may be particularly influenced by inputs from the basolateral
amygdala.8 These shifts in LTP facilitate the plasticity of the hippocampus.1 Importantly, this
plasticity may depend upon the medical history of the individual.12 Whether depression or
potentiation take place in learning may vary throughout the learning process as conditioning and
stimulation change.13 Although both LTP and LTD may play a role in learning, decreases in LTP
have been shown to lead to a decrease in the capability to form long-term memories.15
Other functions of the hippocampus
In addition to learning and memory, other behaviors can be modulated by the
hippocampus. Projections to the PFC are linked to anxiety behaviors, and ones targeting the
nucleus accumbens are implicated in task-oriented activities. Anxiety behaviors have been
suggested to be linked to synergistic action between the hippocampus and the basolateral
amygdala.8 Epileptic and psychotic impairments have also been linked to interruptions between
hippocampal communication with the PFC by inactivation of the intervening mediodorsal
thalamus.13 This link is supported by reported neuronal loss and epilepsy resulting from lesions
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of hippocampal CA fields. NMDA receptor antagonists suppressed the mediodorsal thalamus,
likely dysregulating the inhibitory-excitatory balance in the downstream PFC.13
Neurogenesis, or the production of new neurons in the central nervous system due to
mitosis, occurs in fetal stem cells. However, evidence suggests that multipotent cell precursors
exist in the brain in the hippocampus. Adult hippocampal cell regeneration is hypothesized to
occur in humans and has been shown to replace aged cells in rats. Further, human hippocampal
precursor cells have developed into differentiated cells in vitro. However, neurogenesis has
reportedly been repressed in individuals with post-traumatic stress disorder.1 Additionally,
dysregulation of neurogenesis in the hippocampus has been linked to several neurological
pathologies.16
Sex differences in the brain
Structurally, the male brain contains a larger number of granular neurons in the dentate
gyrus. Additionally, mossy fiber synapses are prevalent in the male hilus and the female CA3.
However, dendritic branch count and spine count in pyramidal basal neurons are increased in
female CA3.3 Dendritic arbors have been observed to be 20% larger in female mice as opposed
to males. This increase in size is observed to spike significantly with the application of
glucocorticoids. Females also have a higher number of corticosteroid-binding globulin levels and
a different ratio of glucocorticoid receptors.2 Additionally, certain parts of the hippocampus
exhibit differential volumes between males and females. The posterior region is larger in
females. While hippocampal volume can change due to early life stress, these changes occur
more frequently in males than females. Connectivity also differs between the sexes. Females
display greater inter-hemispheric connectivity, while males, on the other hand, exhibit greater
intra-hemispheric connectivity.3
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The endocannabinoid system is a key point of difference between the male and female
brain. Cognition, emotion, stress response, and pain are controlled by endocannabinoid lipid
based neuromodulators. When released from a postsynaptic cell, they modulate the amount of
neurotransmitter released.17
A key aspect of the sex difference in the endocannabinoid system involves 17β-estradiol,
a neurosteroid synthesized in the hippocampus. It has been shown to modulate synaptic
transmission by potentiating excitatory hippocampal synapses and suppressing inhibitory ones.
Particularly, endplate synaptic potentials at CA1 pyramidal cells are amplified by this steroid.18
This occurs by activation of NMDA receptors and may play a role in synaptogenesis and the
development of LTP in the hippocampus. 1, 18 Furthermore, early and late LTP has been observed
in larger amounts in male rats compared to females, particularly in CA1 and CA3. Males also
have been shown to have increased CA3 synaptic connections.3
cAMP activated protein kinase A, or PKA, is implicated in the 17β-estradiol potentiation
of female hippocampal neurons. Several other kinases are likewise linked to potentiation;
however, these all were likewise required by male hippocampal neurons. cAMP PKA, on the
other hand, was shown to be required solely by females for potentiation to occur. Further, two
calcium sources are implicated in the development of potentiation in these neurons, including
L-type channels and internal stores. However, either of these sources was sufficient to generate
potentiation from E2 in males, whereas females required both. Other types of synaptic plasticity
have been shown to require PKA only in females. This suggests a crucial difference in molecular
signaling and neuromodulation mechanisms between males and females.18
Further differences surrounding E2 in the hippocampus involve estrogen receptor 2. It
can suppress inhibition at this receptor specifically in females. Nevertheless, this requires the
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activation of the endocannabinoid metabotropic glutamate receptor, mGluR. The result is LTD of
inhibition. This differential inhibition in females is due to differential regulation of these
signaling pathways. Likely, gonadal hormones cause differential signaling of mGluR1 and
estrogen receptor alpha in males and females. Further, once these alternate signaling mechanisms
have been established, they retain their male or female dimorphism even without the continued
presence of gonadal hormones.16
Females exhibit higher levels of estradiol in the brain than males. This may have a
protective effect against brain damage. A higher incidence of damage after ischemia in males
versus females supports this conclusion. Increased resistance to damage in females may be
applicable to the effects of increased glucocorticoids, as well. The release of these compounds is
correlated to high stress, and excessive elevation may lead to neuropathological changes.
Occurrences of such changes have been implicated in depression and post-traumatic stress
disorder. One of the most commonly observed shifts is neural atrophy in CA3, with a particular
decrease observed in hippocampal dendrites. The length and branch point number significantly
decrease.2 Atrophy at CA1 is likewise observed.3
Although atrophy is observed in both sexes, females exhibit much greater atrophy at CA1
and increased resistance to CA3 atrophy than males.2, 3 Similarly, males exhibited a larger
decrease in synaptophysin protein after applied stress, which is crucial to synaptic
reorganization. Further, AMPA receptor GluA2 concentration increased in females with high
glucocorticoid levels, but not males. This indicates a lower influx of calcium in females as
opposed to males, which may result in higher resistance to excitotoxicity. Specific kainate
receptors, another type of receptor implicated in synaptic transmission, namely KA1, were found
in higher amounts in females following stress. The result of these factors indicates that males
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respond more acutely to stress, leading to higher postsynaptic activity and excitotoxic damage.
The increased protection in females is thought to be correlated with the prevention of nervous
system changes during pregnancy when corticoids are present in higher amounts.2
In Alzheimer’s disease, an increase in tau protein and amyloid-β-42, or Aβ-42, levels
were seen in the female hippocampus compared to males. Further, steeper levels of cognitive and
hippocampal volume decrease with disease progression have been observed in females relative to
males.19
O-GlcNAcylation
O-GlcNAcylation is the addition of an N-acetylglucosamine sugar to serine or threonine
residues of intracellular proteins. 7 The sugar uridine-diphosphate-GlcNAc, or UDP-GlcNAc is
the most available high energy metabolite behind ATP and is the substrate for OGT, which adds
O-GlcNAc modifications on to proteins.7, 20 UDP-GlcNAc is a product of the hexosamine
biosynthetic pathway, or HBP, a cycle that utilizes 2-3% of the glucose entering the brain. 6 This
path utilizes adenosine-triphosphate, or ATP, glucose, acetyl-Coenzyme A, or CoA, and uridine.
Since the availability of UDP-GlcNAc is dependent upon glucose metabolism, as well as fatty
acid, amino acid, and nucleotide availability, O-GlcNAc is considered a nutrient sensor that
quickly reveals changes in metabolism throughout the body, as well as cell-specific metabolism.4,
7, 20

A full length and a short isoform of OGT exist, and they may act on different proteins.11

O-GlcNAcase, or OGA, removes this modification, making it a reversible addition. 7;4 OGA can
be selectively inhibited by treatment with thiamet-G. 4 Regulation between OGA and OGT lead
to proper O-GlcNAc cycling within the body.6 The regulation and modification mechanism of
O-GlcNAc can be seen in Figure 3.
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O-GlcNAc is a post-translational modification similar to phosphorylation, a key
modification in the development of learning, memory, and plasticity. 6, 20 These modifications are
mutually exclusive on many proteins. This is supported by observed decreased phosphorylation
on ten eleven translocase, or TET, proteins, leading to increased O-GlcNAcylation. As TET
proteins regulate gene expression, modifications which alter their behavior are critical for
regulation.21 Phosphorylation of proteins is regulated by thousands of phosphatases and
kinases.6,20 O-GlcNAc, however, is strictly regulated by OGT and OGA, both of which are
located in synaptosomes.5,6 OGA can also be found in presynaptic terminals and dendritic
microtubules.5
Figure 3. Regulation and modification mechanisms of O-GlcNAc5

O-GlcNAc is involved in many processes within the cell, including autophagy,
mitochondrial movement, gene expression, and signal transduction. 4 It is also critical for
embryonic development, causing the knockout of the gene Ogt to be embryonic lethal. On the
other hand, the gene Oga knockout can lead to developmental disorders and delay of embryonic
differentiation. Further, malfunction of OGA leads to increased O-GlcNAc levels and several
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typical phenotypes, including high body fat percentage, shortness, and microcephaly.
Additionally, neurogenesis may be prolonged in these conditions. 7
O-GlcNAcylation occurs at higher rates in the brain than the rest of the body. 7 This
correlates with the high glucose intake of the brain, which is the last structure to suffer a
metabolic decrease in starvation and utilizes 20% of the glucose that enters the body. As a result,
shifts in glucose levels make the brain particularly susceptible to dysregulated neurogenesis.22
Once glucose has been converted to O-GlcNAc, this modification is added in notably increased
levels in the hypothalamus, cortex, and hippocampus compared to other regions. 4 Particular
O-GlcNAc density is observed at CA1 pyramidal neurons and GABAergic interneurons.5 This
may be due to the high glucose consumption of the brain, totaling 60% of the body’s total supply.
Several functions, including the growth of axons and dendrites, neuronal metabolism, and neural
degeneration, are regulated by this modification. 7 A few critical regulatory proteins are known to
be O-GlcNAcylated, including Sox2, Nanog, Sox1, Otx2, NR2A, NR2B, PSD-95, and
synapsin1. 7, 11 Mouse models have demonstrated that proper O-GlcNAc turnover is crucial to
maintaining correct levels of these proteins, which go on to regulate the cell’s
neurodevelopment.22 Several key receptors involved in the development of LTD and LTP are
O-GlcNAcylated. This includes the AMPA GluR2 subunit, NMDA, and protein kinase C at
CA1-CA3 synapses.11 O-GlcNAcylation of AMPA GluR2 subunits may lead to decreased
phosphorylation of the GluR1 subunits.20
O-GlcNAcylation of these proteins leads to modulation of the flow of cations through
voltage gated channels. These include voltage gated potassium channels, leading to an increase
in outward current and decreased excitability. Further, O-GlcNAcylation leads to a decrease in
sodium influx through sodium voltage gated channels. This further depolarizes the cell, and the
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reduced flow can lead to endocytosis of AMPA GluR2. Hyperpolarization of cyclic-nucleotide
gated channels is also impacted by O-GlcNAc levels. The dampening effect of flux through
sodium and potassium channels in particular has been specifically observed at CA1 synapses.
Current through these channels reduces excitability, a phenomenon increased by more
O-GlcNAc. The high prevalence of these channels in apical dendrites heightens this effect in this
area. 4 As a result, O-GlcNAcylation at these proteins induces a particular form of LTD to this
hippocampal synapse.11 This may allow for a break in LTP, resulting in the protective role of this
modification discussed previously.5
Because LTD is crucial to certain aspects of learning, O-GlcNAc has been shown to play
a role in the development of hippocampal learning and memory. Further, an increase in this
modification has been linked to increased associative-fear memories. Alterations of this
modification have been linked to differences in spatial memory, as well.11 Performance in novel
object placement and recognition tasks has reportedly decreased with higher O-GlcNAc,
however.20 Memory processing and synaptic efficiency are reportedly modulated by shifts in
O-GlcNAcylation.5 Regulation of differentiation and proliferation of neural cells depends on the
amount of O-GlcNAc present and is key for development of proper neuronal structures. Higher
than normal levels of O-GlcNAc have been observed to result in lower amounts of hippocampal
pyramidal neurons. 7
O-GlcNAcylation, cognitive decline, and disease
Neural O-GlcNAcylation has been shown to aid in cognitive rehabilitation in aged mice.
Age comes with a reduction in synaptic and plasticity changes, as well as a reduction of OGT
levels. Similar shifts have been observed in Alzheimer’s disease. Further, a decrease in the levels
of O-GlcNAcylation of NR2A, NR2B, PSD-95, and synapsin1 has been observed with this
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reduction. However, studies indicate that restoration of these enzyme levels restore cognitive
function, likely due to O-GlcNAc’s impact on LTP and LTD shifts that are crucial for memory
formation.11
Phosphorylation is likewise linked to Alzheimer’s disease and O-GlcNAc. Because
phosphorylation and O-GlcNAcylation of tau proteins are mutually exclusive, decreased
O-GlcNAc is often observed in cases of hyperphosphorylation, regardless of OGA and OGT
levels. Triple transgenic mice, meaning three mutations are present, have been created to mimic
Alzheimer’s patients and have displayed heightened levels of phosphorylation at tau protein
Serine residue 396 and Thr residue 205, termed Ser396 and Thr205, in the hippocampus. 23
However, a particular modification that has been shown to have ameliorative effects in
Alzheimer’s is O-GlcNAcylation of tau protein Ser400.5 Together, these data demonstrate that
lower O-GlcNAc is considered a crucial aspect of cognitive decline and increase may be a
possible treatment for age and neuronal disease-related impairments.11
Triple transgenic mice that have been used to model Alzheimer’s patients and display a
decrease in O-GlcNAcylation have led to other pathological considerations. Increased anxiety
and depressive behaviors were observed in these mice, indicating a possible link between these
mental disorders and O-GlcNAc levels.23 Other cognitive maladies associated with O-GlcNAc
include Huntington's and Parkinson’s disease.22 Many proteins that aggregate in
neurodegenerative disorders are O-GlcNAcylated.22
Particular focus has been placed on the role of O-GlcNAc as a potential treatment for
seizures. This is because epileptiform activity is a result of hyperexcitability, meaning the
protective aspect of O-GlcNAc could ameliorate epilepsy.20 Studies have found the upregulated
neurogenesis with higher O-GlcNAc levels to correlate with lower neurodegenerative damage.
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These results indicate that lower OGA levels or inhibition of this enzyme may be protective. 7 An
increase in OGT may likewise serve this purpose.11
O-GlcNAcylation has further been implicated in diseases with dysregulated sugar levels,
such as diabetes and obesity. 4 Because O-GlcNAcylation is dependent upon glucose metabolism,
defects in brain glucose uptake that come with these diseases are correlated with lower brain
O-GlcNAc levels. Insulin and insulin-like growth factor, or IGF, resistance may lead to defective
glucose consumption and decreased cycling through the HBP. As a result, the protective effects
of O-GlcNAc on synaptic activity are decreased. The importance of O-GlcNAc neural protection
is observed particularly in the hippocampus due to this structure’s critical role in learning and
memory. Alzheimer’s disease pathologies can arise without this protection, including a decrease
in hippocampal spatial memory Therefore, a link between diabetes, O-GlcNAc, and the
development of Alzheimer’s disease can be established. 23
Other pathologies related to diabetes and O-GlcNAc include heart disease. Acute
hyperglycemia is linked to O-GlcNAcylation of Ser279 on calcium/calmodulin-dependent
protein kinase II, or CamKII, a regulatory protein in the heart and brain. This causes its
activation, which may lead to changes in channel activation, calcium ion flow, and gene
transcription. Calcium ion release from the sarcoplasmic reticulum in particular is linked to heart
arrhythmias. As diabetic individuals have higher glucose levels in their blood, more substrate is
available for O-GlcNAcylation. Therefore, they show higher rates of CamKII O-GlcNAcylation
in the heart and brain and are particularly susceptible to heart arrhythmia pathology. Individuals
with diabetes reportedly show twice as much O-GlcNAcylation in heart CamKII and are almost
three times as likely to develop heart failure.24 As a result of O-GlcNAc’s simultaneous role in
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cognition, these conditions are often observed along with impaired memory and brain function.
In particular, dementia and neurodegeneration are often correlated to diabetes.4
O-GlcNAcylation and sex differences
The gene for OGT is located on the X chromosome. Therefore, dosage compensation in
females is critical for maintaining proper levels of OGT. Random X-inactivation silences one X
chromosome to ensure that the same amount of transcription occurs in females as in males.
However, about 15% of genes remain active on the silenced chromosome and are biallelicly
expressed. In embryonic tissues, the gene Ogt on the paternally inherited X chromosome is
preferentially silenced. This is due to epigenetic X chromosome silencing, whereas random X
inactivation silences the maternal and paternal X in equal proportions. Outside of embryonic
tissues, Ogt can escape X inactivation. Therefore, the amount of OGT present and resulting
disease phenotypes may be different based on sex. Notably, photoblast stem cells and placentas
in females have higher OGT levels than in males. Additionally, lowered placental OGT has been
linked to the presentation of neurological disease. Nevertheless, OGT is typically expressed
equally in males and females except in the adrenal glands. 6
In light of the impact of O-GlcNAcylation on hippocampus structure and function and
potential differences by sex, the regulation and differential expression of this modification may
impact key functions of the hippocampus. As learning and memory are included in these
functions, studies involving shifts in O-GlcNAc and its regulatory enzymes are important in
understanding these processes. Furthermore, as OGA regulates O-GlcNAc, quantifying how
variable expression of this enzyme shifts O-GlcNAc levels is crucial. OGT likewise regulates
O-GlcNAc, and as sex differences with this enzyme are proposed, validation of these differences
is necessary.
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Methodology
This study aims to investigate the levels of OGT, the levels of OGA, and the levels of
O-GlcNAc in the hippocampus of male versus female mice. Western blot analysis, a method of
detecting and quantifying proteins in a sample, was utilized to measure OGT, OGA, and
O-GlcNAcylatyed protein levels in mice with differential OGA expression. 25 This analysis
utilizes electrophoresis to push proteins through a polyacrylamide gel and separate proteins
based on their respective sizes. Proteins contain a negative charge, resulting in migration from
the negative electrode to the positive electrode with lower molecular weight proteins moving
faster through the gel and therefore traveling further.25,26 The basic procedure can be seen in
Figure 4.
Figure 4. Western blot procedure27
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Genetic model
Purpose
Considering knockout of Oga in mice leads predominantly to perinatal lethality, this
system is useful for generating differential OGA expression. Tet-On and Tet-Off systems are a
method of controlling gene expression based off of the Tet repressor protein, or TetR, and Tet
operator, TetO, in the Tet operon of Escherischia coli. In Tet-Off systems, transcription
activation domain combined to TetR allows for production of transcription activator, or tA. TetO,
positioned in front of the gene of interest, binding to tA activates transcription of the gene.
Binding of tetracycline or its derivative doxycycline to tA prevents binding to TetO. This in turn
prevents transcription of the gene of interest. Without doxycycline, tA can bind TetO, thus
allowing gene transcription. The Tet operon, Tet-On, and Tet-Off systems can be visualized in
Figure 5. This experiment utilized such a system, administering doxycycline to certain mice to
prevent OGA expression and stopping administration to others to allow expression. The mice
were identified by a number corresponding to their cage number and ear tag.28
Figure 5. Tet operon, Tet-On, and Tet-Off systems 28
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Obtaining and homogenizing the samples
Mice utilized in this experiment were placed in an isoflurane chamber to render them
unconscious. This was followed by sacrifice with a guillotine. rains were then dissected by
subfield over dry ice. Hippocampal, cerebellar, and frontal cortex sections were placed in
separate labeled test tubes and left to sit in liquid nitrogen for several hours. The samples were
then moved to -80°C.29
In order to extract proteins and allow storage at -20°C, all tissues were then
homogenized. Lysis buffer was prepared by mixing a ratio of one microliter of protease inhibitor
and one microliter of phosphatase inhibitor to 100 microliters of Tissue Protein Extraction
Reagent. 400 microliters of the prepared buffer were added to each sample tissue followed by 30
seconds in the homogenizer at medium speed. The samples were allowed to sit on ice for 30
minutes. In a 4°C environment, the samples were centrifuged at 3,200G for 15 minutes. The
pellets were discarded, and the supernatants were stored in fresh tubes at -20°C.29
Table 1. Mice Utilized
ID number

On/Off doxycycline

Genotype

Sex

1058

On

WT

M

1038

On

WT

M

1008

On

WT

M

1056

On

CAMK tTA+TREOGNgk

M

1023

On

CAMK tTA+TREOGNgk

M

1022

On

CAMK tTA+TREOGNgk

M

1063

Off

WT

M

1043

Off

WT

M

977

Off

WT

M
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1045

Off

CAMK tTA+TREOGNgk

M

1044

Off

CAMK tTA+TREOGNgk

M

1026

Off

CAMK tTA+TREOGNgk

M

1004

On

WT

F

1033

On

WT

F

1054

On

WT

F

969

On

CAMK tTA+TREOGNgk

F

996

On

CAMK tTA+TREOGNgk

F

1021

On

CAMK tTA+TREOGNgk

F

1003

Off

WT

F

1017

Off

WT

F

1032

Off

WT

F

1002

Off

CAMK tTA+TREOGNgk

F

1018

Off

CAMK tTA+TREOGNgk

F

1034

Off

CAMK tTA+TREOGNgk

F

Western blot
Sample buffer was prepared by adding nine parts 4x Laemmli sample buffer to one part
beta-mercaptoethanol, or BME, and stirring with a vortex mixer. Each sample was prepared by
adding 3.3 microliters of sample buffer solution and 14.7 microliters of de-ionized (DI) water to
a micro test tube with 2 microliters of the homogenized tissue. The micro test tubes with
prepared samples were then placed in a 70°C for 10 minutes.29,30
7.5% polyacrylamide gels were handcast with Bio-Rad Mini-PROTEAN® Tetra handcast
systems reagents and according to the included guidelines for 1.5 mm glass plates. Gels were
placed in an upstand in the electrophoresis chamber. Runner buffer was made by adding 900 mL
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DI water to 100 mL of Tris-glycine buffer. Buffer was then poured into the upstand. A
micropipette was used to load two microliters of the ladder protein standard solution into the first
well of the gel and 20 microliters of sample 1058, 1063, 1004, 1003, 1056, 1045, 969, and 1002
into each successive well. This was repeated on a second gel with samples 1038, 10443, 1033,
1017, 1023, 1044, 996, and 1018 and then on a third gel with samples 1008, 977, 1054, 1032,
1022, 1026, 1021, and 1034. The electrophoresis chamber was closed and run at 200 volts for 40
minutes to push proteins down the gel.31
The transfer buffer was prepared by mixing 700 mL DI water, 100 mL Tris-glycine
buffer, and 200 mL methanol. A piece of polyvinylidene fluoride, or PVDF, paper was cut to
match the size of the gel, rinsed in methanol, and left to sit in the transfer buffer for 10 minutes.
Two sponges and two pieces of filter paper were let to sit in the buffer for 10 minutes, as well.
The gel was removed from the chamber, the glass plates were separated, and the gel was
removed from the plates. One of the sponges and pieces of filter paper were placed in the bottom
black side of a cassette followed by the gel, PVDF paper, another filter paper, and another
sponge. The cassette was closed and placed in the electrophoresis chamber. Transfer buffer, a stir
bar, and an ice pack were added to the chamber, which was placed on a stir plate in a 4°C
environment. The chamber was run at 100 volts for one hour. The PVDF paper was then
removed from the chamber and allowed to dry.30,31
Specific aim I: To determine the concentration of OGA relative to actin in male and female
mice, both on and off doxycycline
Six male mice on doxycycline, six male mice off doxycycline, six female mice on
doxycycline, and six female mice off doxycycline were tested. Three of each group were wild
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type mice, and three of each were O-GlcNAc knockdown models with the mutation CAMK
tTA+TREOGNgk.
Each gel was washed in 1X Tris-buffered saline with 1% Tween, or TBST for five
minutes with agitation. The gel was then blocked with 5% milk, made from five grams
dehydrated milk mixed with 100 mL TBST, with agitation for one hour. This was followed by
three 15 minute washes with TBST. The blot was then incubated in two microliters of OGA
primary antibody generated in rabbit diluted in four mL 5% milk in a 4°C environment with
agitation overnight. The gel was then washed with TBST for 10 minutes four times with
agitation. It was then incubated in two microliters goat-anti-rabbit secondary antibody diluted in
four mL 5% milk for one hour at room temperature with agitation. This was followed by three 15
minute TBST washes. 25
The blot was developed by rinsing in enhanced chemiluminesence solution for 5 minutes
with agitation. The blot was exposed for .5-40 seconds with the Bio Rad Chemi Doc Imager.25
The blot was washed in a stripping buffer for five minutes, then the process was repeated
with actin primary antibody in order to normalize the amount of OGA to actin. This was then
repeated with two more blots to enable statistical analysis.25
Specific aim II: To determine the concentration of OGT relative to actin in male and female
mice, both on and off doxycycline.
Six male mice on doxycycline, six male mice off doxycycline, six female mice on
doxycycline, and six female mice off doxycycline were tested. Three of each group were wild
type mice, and three of each were O-GlcNAc knockdown models with the mutation CAMK
tTA+TREOGNgk.
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Each gel was washed in TBST for five minutes with agitation. The gel was then blocked
with 5% milk, made from five grams dehydrated milk mixed with 100 mL TBST, with agitation
for one hour. This was followed by three 15 minute washes with TBST. The blot was then
incubated in two microliters of OGT primary antibody generated in rabbit diluted in four mL 5%
milk in a 4°C environment with agitation overnight. The gel was then washed with TBST for 10
minutes four times with agitation. It was then incubated in two microliters goat-anti-rabbit
secondary antibody diluted in four mL 5% milk for one hour at room temperature with agitation.
This was followed by three 15 minute TBST washes. 25
The blot was developed by rinsing in an enhanced chemiluminescence solution for five
minutes with agitation. The blot was exposed for 0.5-40 seconds with the Bio Rad Chemi Doc
Imager.25
The blot was washed in a stripping buffer for five minutes, then the process was repeated
with actin primary antibody in order to normalize the amount of OGA to actin. This was then
repeated with two more blots to enable statistical analysis.25
Specific aim III: To determine the concentration of O-GlcNAc relative to actin in male and
female mice, both on and off doxycycline.
Six male mice on doxycycline, six male mice off doxycycline, six female mice on
doxycycline, and six female mice off doxycycline were tested. Three of each group were wild
type mice, and three of each were O-GlcNAc knockdown models with the mutation CAMK
tTA+TREOGNgk.
Each gel was washed in TBST for five minutes with agitation. The gel was then blocked
with 5% milk, made from five g dehydrated milk mixed with 100 mL TBST, with agitation for
one hour. This was followed by three 15 minute washes with TBST. The blot was then incubated
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in two microliters of O-GlcNAc primary antibody generated in mouse, diluted in four mL 5%
milk in a 4°C environment with agitation overnight. The gel was then washed with TBST for 10
minutes four times with agitation. It was then incubated in two microliters goat-anti-mouse
secondary antibody diluted in four mL 5% milk for one hour at room temperature with agitation.
This was followed by three 15 minute TBST washes. 25
The blot was developed by rinsing in enhanced chemiluminescence solution for five
minutes with agitation. The blot was exposed for 0.5-40 seconds with the Bio Rad Chemi Doc
Imager.25
The blot was washed in a stripping buffer for five minutes, then the process was repeated
with actin primary antibody in order to normalize amount of O-GlcNAc to actin. This was then
repeated with two more blots to enable statistical analysis.25
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Data Analysis
A representative Western blot demonstrating OGT, OGA, and O-GlcNAc relative to actin
is shown below in Figure 6. One sample of each type is included, with the genetic makeup, sex,
and doxycycline status listed in Table 1.
Sample

1038 1043 1033 1017 1023

1044

996

1018

a. OGT (MW 117 kD) 32
Actin (MW 42 kD)33

b. OGA (MW 130 kD) 34
Actin (MW 42 kD)33

c. O-GlcNAc (variable MW)35
Actin (MW 42 kD)33

Figure 6. a. OGT representative western blot, b. OGA representative western blot, c. O-GlcNAc
representative western blot
BioRad ImageLab software was used to analyze the pixels in each sample, and pixels of
each antibody were normalized relative to actin. Three Western blots were run, with one sample
of each type in each blot, creating an n=3. The first blot was run twice, and the second and third
blots were run three times. The separate runs were used to calculate the averages of normalized
levels for each blots. As each blot contained one sample of each type, the means and standard
errors of each type were determined from these averages. These are displayed in Figure 7-9, with
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WT M On indicating wild type males on doxycycline, WT M Off indicating wild type males off
doxycycline, WT F On indicating wild type females on doxycycline, WT F Off indicating wild
type females off doxycycline, Mut M On indicating OGA knockdown mutant males on
doxycycline, Mut M Off indicating OGA knockdown mutant males off doxycycline, Mut F On
indicating OGA knockdown mutant females on doxycycline, and Mut F Off indicating OGA
knockdown mutant females off doxycycline.
Figure 7. Mean OGT relative to actin by sample type

Figure 8. Mean OGA relative to actin by sample type
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Figure 9. Mean O-GlcNAc relative to actin by sample type

Relative OGT to actin was found to be 1.95±5.70 in WT M On, 0.63±0.14 in WT M Off,
0.58±0.06 in WT F On, 0.77±0.25 in WT F Off, 0.74±0.24 in Mut M On, 1.43±2.02 in Mut M
Off, 0.89±0.39 in Mut F On, and 0.86±0.44 in Mut F Off. Relative OGA to actin was found to be
0.84±1.16 in WT M On, 0.37±0.07 in WT M Off, 0.32±0.03 in WT F On, 0.36±0.05 in WT F
Off, 0.35±0.13 in Mut F On, 0.35±0.03 in Mut F Off, 0.40±0.10 in Mut F On, and 0.43±0.19 in
Mut F Off. Relative O-GlcNAc to actin was found to be 0.33±0.07 in WT M On, 0.45±0.13 in
WT M Off, 0.57±0.29 in WT F On, 0.37±0.09 in WT F Off, 0.26±0.05 in Mut F On, 0.43±0.04
in Mut F Off, 0.46±0.12 in Mut F On, and 0.48±0.09 in Mut F Off.
Statistical analysis was performed using a Student’s paired t-test for two samples
assuming equal variances. Hypothesized mean difference was set to zero for all comparisons.
Differences were considered statistically significant if one tailed p values were less than 0.05.
However, no samples displayed significant differences for any antibody.
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Conclusion
Wild type mice acted as controls, and were expected to have the same amounts of OGA,
OGT, and O-GlcNAc relative to actin when on or off doxycycline. This was shown to be true in
both males and females. OGA knockdown mice were not expected to display this same trend.
When on doxycycline, the drug binds tA to prevent expression of OGA. Therefore, lower levels
of OGA were expected to be observed in mutant mice on doxycycline versus mutant mice off
doxycycline. However, no statistically significant difference was found in mutant male or female
mice. Additionally, the hypothesized decrease of OGA expression in mutant mice on
doxycycline would result in an decrease in removal of O-GlcNAc from serine and threonine
residues. Therefore, an increase in O-GlcNAcylated proteins was hypothesized to occur in
mutant mice on doxycycline. Nevertheless, no statistically significant difference was found in
O-GlcNAcylated proteins relative to actin in male or female mutant mice. These findings
indicate that mice off of doxycycline had not yet been off of the drug for long enough to create a
significant OGA expression difference. Therefore, a longer period of time off of doxycycline is
hypothesized as necessary to create a change. As OGT remained unaffected by the
administration of doxycycline, no statistically significant differences were expected in this
antibody relative to actin between mutant mice on and off doxycycline, which was found to be
true.
Furthermore, it was hypothesized that females may display increased OGT relative to
males due to the additional X chromosome they possess, whether mutant, wild type, on
doxycycline, or off doxycycline. This would in turn produce an increase in O-GlcNAcylation.
However, no significant difference in OGT relative to actin or O-GlcNAc relative to actin was
observed between wild type males and females or mutant males and females on doxycycline or
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mutant males and females off doxycycline. Therefore, the data suggests that male and female
brains express the same relative amount of OGT, and the second X chromosome found in
females does not alter expression of this enzyme.
Strengths of the study
Several aspects of this study lent strength to the analysis and results. Each blot contained
eight samples and was run two to three times with averages of the runs calculated. This was done
to reduce any error that may have occurred during one particular run. Additionally, each blot
contained one of each sample type. Therefore, three of each sample type were utilized, creating
an n=3. This allowed for proper statistical analysis to be done and reduced error that may have
resulted from one particular sample. Further, the samples were run blind to reduce bias. This
meant the genotype, sex, and doxycycline status of each sample was unknown during the
procedure, so the analysis of each was not skewed
Weaknesses of the study
Other aspects of this study weakened the analysis and results. While an n=3 allows for
statistical analysis, it is the lowest level that does. Additionally, samples and antibodies utilized
went through repeated freeze/thaw cycles. This may have impacted the protein content and
antibody binding ability. Further, the use of actin as a loading control is a less accurate method
than a BCA protein assay. As a result, the relative amounts of OGT, OGA, and O-GlcNAc may
be skewed.
Future directions
This study indicated that no difference exists between OGT, OGA, and O-GlcNAc levels
in the hippocampus of OGA knockdown and wild type male and female mice on and off
doxycycline. In the future, additional samples of each type should be analyzed to increase the n
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value and add credibility to the conclusions. Furthermore, differences in subregions might be
present but are diluted by combining CA3, CA1, CA2 and dentate gyrus as was done in this
study. Additionally, other brain regions should be analyzed to determine if OGA and O-GlcNAc
present differently between groups in regions other than the hippocampus. Future studies may
also examine if OGA and O-GlcNAc levels are found to be different between mice on and off
doxycycline after a longer period of time off of the medication.
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Appendix A: List of Abbreviations
O-GlcNAc………………………………………………..………O-linked β-N-acetylglucosamine
OGA…………………………………………………………………………………O-GlcNAcase
OGT………………………………………………..……………………….O-GlcNAc transferase
GABA………………………………………………..………………...Gamma-aminobutyric acid
LTP………………………………………………..…………………….….Long term potentiation
LTD………………………………………………..…………………….…..Long term depression
NMDA………………………………………………..……………………..N-methyl-D-aspartate
AMPA…………………………………..α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
cAMP………………………………………………..………….Cyclic adenosine monophosphate
PFC………………………………………………..…………………………..….Prefrontal cortex
PKA………………………………………………..…………………….…….….Protein kinase A
mGluR………………………………………………..…...….….Metabotropic glutamate receptor
Aβ-42………………………………………………..………………..……….….Amyloid-beta 42
UDP………………………………………………..…………..,………….….Uridine diphosphate
ATP………………………………………………..…………...……….….Adenosine triphosphate
CoA………………………………………………..……………………...……….….Coenzyme A
TET………………………………………………..……………..Ten-eleven translocation protein
IGF………………………………………………..……………………..Insulin-like growth factor
HBP………………………………………………..………..….Hexosamine biosynthetic pathway
CamKII………………………………………….Calcium/calmodulin-dependent protein kinase II
TetR………………………………………………..……………………....….Tet repressor protein
TetO………………………………………………..……………………………….….Tet operator
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tA………………………………………………..…………...………….….Transcription activator
BME………………………………………………..…………………….….Beta-mercaptoethanol
PVDF………………………………………………..…………………..Polyvinylidene difluoride
TBST………………………………………………..………..Tris-buffered saline with 1% Tween

